Navigation Links


Pattern in Medical Technology

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... will receive injections in a distribution pattern that targets the major peripheral nerves in the ... Subjects receive injections in a distribution pattern that targets the major peripheral nerves in the ... Subjects will receive injections in the same pattern used in the initial part of the trial. The ...

Video: New Research Discovers Independent Brain Networks Control Human Walking

... one leg moving forward and the other backward, a pattern referred to as "hybrid walking." Adaptation of ... learned to walk smoothly with a normal pattern and rhythm, as verified by computer models. This ... types of brain damage can store a new walking pattern in the short term. Based on these findings, ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... and a mean of 54 mL less FVC decline in CAPACITY 1 (p=0.006). This pattern of change is consistent with that observed at Week 52 in the Phase 3 study ... overall Grade 4 adverse events between pirfenidone and placebo. The pattern of adverse events was in general comparable to that observed in previous ...

Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth

... in the treatment of Androgenetic Alopecia in males commonly known as 'male pattern baldness' - BOCA RATON, Fla., April 20 /PRNewswire/ -- Findings of ... distressing condition." Mr. Stillman also noted that male pattern baldness affects more than 50 million men in the U.S. and many more ...

Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange

... study of the Company's proprietary information technology platform, Muscle pattern Recognition (MPR). MPR is a unique clinical tool that analyzes patterns ... To date, it has focused on developing a proprietary platform called Muscle pattern Recognition (MPR), a unique clinical tool for the analysis of muscle ...

Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs

... (human clones) and human-to-animal clones (hybrids) appear similar, the pattern of reprogramming of the donor human cell is dramatically different. In contrast to the human-animal hybrids, the gene expression pattern of the human clones was highly similar to normal human embryos. The paper ...

Impact Medical Solutions Announces Appointment of New Director and Corporate Update

... in the development of its proprietary medical technology, the Muscle pattern Recognition (MPR) System. "The MPR System continues to perform well in ... To date, it has focused on developing a proprietary platform called Muscle pattern Recognition (MPR), a unique clinical tool for the analysis of muscle ...

Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's

... retention in the brain. Two individuals diagnosed with Alzheimer's had a pattern of tracer uptake similar to healthy volunteers. Chart notes for both ... dementia in the other. While the three compounds were similar in pattern and amount of tracer retention, they differed in how they were processed ...

BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial

... receiving Tavocept. This is the second Tavocept clinical trial where this pattern of survival increase has been observed. Tavocept is an investigational ... and the taxane drug paclitaxel, BioNumerik has also now observed this pattern of a Tavocept increase in survival in first-line non-small cell lung ...

New Australian Technology: Detecting Breast Cancer With Hair

... This change is seen as a ring superimposed on the normal X-ray diffraction pattern of hair. [See images on http://www.australiabio2008.com/FermiscanNMR.php ... Meyer P, James VJ. Experimental confirmation of a distinctive diffraction pattern in the hair from women with breast cancer. J Natl Cancer Inst ...

Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs

... treatments (Day 0 and 90). Subjects receive injections in a distribution pattern that targets the major peripheral nerves in the legs and feet. The ... (Day 0, 60 and 120). Subjects will receive injections in a similar pattern to that used in the initial part of the trial. "In our Phase 1 studies ...

Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years

... presented -- a post hoc analysis -- showed that AVODART provides a pattern of increasing enlarged prostate symptom improvement over 24 months. ... According to the post hoc analysis, AVODART monotherapy resulted in a pattern of continuous and increasing symptom improvement over 2 years (IPSS at ...

Is Your Hair Taking a Break?

... most common form of hair loss in women is female-pattern hair loss, which is a hereditary condition also referred to as androgenetic alopecia. While pattern hair loss affects both men and women, it is very different in women and does not display the classic receding hairline or bald spot on top of the ...

July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair

... General attitude in life is likely a combination of nature and nurture -- genetics combined with life experiences. Changing one's thinking pattern can be challenging, but it's possible. Change begins with awareness of negative thought patterns. For some people, self-help measures can ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... as a phase 1 clinical study on the new compound RK-023 that is being developed by our company as a therapeutic drug of androgenetic alopecia (male pattern baldness; see the note below) has been completed. The phase 1 clinical study of RK-023 consisted of a patch test (open, closed, photo-patch ...

Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity

... The publication describes the analyses of three distinct classes of ERb selective drugs. The study determines the relative ER selectivity and pattern of gene expression of the three classes of ERb selective compounds compared to the natural hormone estradiol, which non-selectively regulates both ...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

... other age-sensitive cognitive skills also change, memory, specifically, appears to decline more quickly in APOE e4 gene carriers, and it is this pattern of cognitive aging that is similar to (but much milder than) what we expect to see in patients with Alzheimer's disease. This suggests that seemingly ...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

... consciousness. Epilepsy is a disorder with many possible causes. Often the cause of epilepsy is unknown. However, anything that disturbs the normal pattern of neurone activity - from illness to brain damage to abnormal brain development, can lead to seizures. Epilepsy is characterised by abnormal ...

Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting

... by 8 weeks safety follow-up. Botulinum neurotoxin doses were derived from the recommendations from the organization WE MOVE. The individual injection pattern was adapted to patient's needs. A two-sided 95% Newcombe-Wilson confidence interval [CI] for the difference between groups was calculated. ...

New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)

... and over, approximately 9.8 million adults are believed to have ADHD. ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of ...

Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms

... according to the Centers for Disease Control and Prevention (CDC). ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of ...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

... serious infections in the treatment group (25 vs. 3), although these were not linked to neutropenia. None were unexpected events, nor was there a pattern to them. In the primary analysis, PEGINTRON maintenance therapy was not superior to observational control in preventing the occurrence of ...

AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne

... for the treatment of both males and females. In addition to acne indication, AndroScience is currently pursuing androgenetic alopecia (male pattern baldness), and wound healing using topical based formulations; and prostate cancer, benign prostatic hyperplasia, and spinal bulbar muscular atrophy ...

New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation

... wrinkles, fine lines, and acne scarring. Unlike any other skin resurfacing CO2 laser, the DOT system is unique because it ablates a customized pattern of tiny, micro-sized dots, rather than the entire skin surface. This results in the creation of very tiny columns of thermal damage that penetrate ...

Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer

... subjects withdrew from the study because of study drug, and no serious adverse events (AEs) were reported. AEs were usually mild in severity with no pattern of body-system AEs. The most common AEs reported were headache, nausea/emesis and diarrhea. Furthermore, there were no statistically significant ...

Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial

... only 25% of the 10 mg group (p < 0.0001) required more than one dose of study drug and/or rescue medication. A similar statistically significant pattern was evident for the 24-hour time point. A responder analysis was conducted using the CGI-I scale. A responder was defined as having a CGI-I ...

Siemens Introduces New Standard of Care for Breast Ultrasound

... across their all-new ACUSON ultrasound product line, which automate and streamline a broad range of routine clinical tasks. Using learned pattern recognition from an expert database of thousands of clinical cases, knowledge-based workflow applications recognize anatomical patterns and landmarks ...

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

... and an insidious spread of infection throughout the herd. Diagnosis of paratuberculosis is difficult because of the fastidious growth pattern of the microorganism and because of the paradoxical immune response of the host animal to infection. During the early sub clinical stages of ...

New Insight Into the Controls on a Go-To Enzyme

... first crystallize a protein to be studied. Then, they direct X-rays through the crystal and deduce the protein structure from the diffraction pattern of those X-rays. To overcome the crystallization bottleneck, a lengthy and unpredictable variable in X-ray crystallography, the investigators used ...

Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

... duration in more patients are known. All reported adverse events were classified as mild or moderate, with no apparent dose relationship and no pattern of events within any body system. The pharmacokinetic profile demonstrated sustained plasma levels of ANA598 with a half-life of 24 to 30 hours in ...

Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

... (cSSSIs). Paratek's trial met its primary safety and tolerability endpoint, demonstrating no differences between PTK 0796 and Zyvox in incidence or pattern of adverse events (AEs). Of note, no patients discontinued therapy with PTK 0796 because of AEs, and no drug-related serious adverse events (SAEs) ...

DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing

... body skin tightening and improvement of crepe skin. -- The SmartXide DOT laser system has the unique capability to deliver a customized pattern of tiny, micro-sized dots, rather than treating the entire skin surface, so healing is fast. DOT Therapy has been introduced through an ...

St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins

... In this widely used technique, X-rays are directed through the crystal of a protein to be analyzed and its structure deduced from the pattern of diffraction of the X-rays. Comparison of the two structures revealed that, when NEDD8 attaches to cullin-RING, it dramatically modifies the ...

Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients

... point, as per the statistical analysis plan, but the mean changes in PEC scores demonstrated a dose response at all time points. A dose response pattern for AZ-004 was also apparent, as measured by the need for a patient to require more than one dose of study drug by the 4-hour post-first dose time ...

Study Shows Benefits of a High Omega-3 Diet in Older Adults

... Director at KLRI. "We wanted to see if we could improve mental function, hormone levels at rest and/or under stress, and immune function, toward a pattern more like that of younger individuals." In this study, all participants were given a conventional Western diet with defined fat and daily intake of ...

FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors

... has cleared its Pathwork(R) Tissue of Origin Test for use in determining the origin of uncertain tumors. The test analyzes a tumor's gene expression pattern to help pinpoint the source of hard-to-identify tumors and is the first test of its kind to receive FDA clearance. Up to an estimated 200,000 newly ...

Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies

... the PSG data for the Phase 2a trial. "In the trial, APD125 clearly demonstrated robust sleep maintenance properties without any apparent pattern of side effects associated with the drug." Arena is currently evaluating the effects of APD125 on patients' subjective assessment of sleep in a ...

Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose

... at least three times per week and 23 percent waking up at least once every night. Ninety percent of the MOTN insomnia population report that their pattern of awakenings persists for at least six months and 50 percent report such insomnia problems lasting more than 5 years. Currently, there is no ...

Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008

... at least three times per week and 23 percent waking up at least once every night. Ninety percent of the MOTN insomnia population report that their pattern of nocturnal awakenings persists for at least six months and 50 percent report such insomnia problems lasting more than 5 years. Currently, there is ...

Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO

... components were also observed at this dose level in surrogate patient tissues, including hair bulbs, skin, and peripheral blood cells. The pattern of inhibition of protein phosphorylation observed in these tissues is consistent with observations from preclinical studies, and suggests that XL765 ...
Other Contentswhiplashwhiplashcoughcoughcoughcoughwhoopingwhoopingwhoopingspacedspacedspacedspacedspacedwidelywidelywidelywidelywidelywidelywidelywidelywidelywidelywindwindwindwindwindwormswormswormswormswormswormswoundswoundswoundswoundswounds
(Date:11/30/2009)... HIV research is the virus,s exquisite specialisat...raditional tools, like the humble lab mouse, can d...searchers writing in BioMed Central,s open access ...t on this problem by creating a mouse that has key...with HIV. , George Kassiotis, from the Division ...
(Date:11/30/2009)...rt published in the December 2009 print issue of T...type of control over their fertility that women ha...have found how and where androgenic hormones work ...nd male fertility. This opens a promising avenue f...overy also offers hope to those who cannot have ch...
(Date:11/30/2009)...ess and odorless radioactive gas that is produced ...oduct of uranium decay and is found in trace amoun...dwater as well as building materials, plants, anim...is expressed as the amount of radiation that would...iter of air; thus the units are picocuries per lit...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Weeds that reinvented weediness 9780 1ViroPharma to Present at Several Upcoming Healthcare Conferences 13834 1ViroPharma to Present at Several Upcoming Healthcare Conferences 13834 2Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 1Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 2Choco Milk Initiates Adventure Filled Mobile Tour That Teaches Children Nutrition Awareness 56143 3
(Date:12/1/2009)... Global measles deaths dr... (Vocus) December 1, 2009 -- WHAT: Meas..., U.S. Centers for Disease Control and Prevention,...rld Health Organization – will announce the ...leconference on Thursday, December 3, 2009 at 10:0...
(Date:12/1/2009)..., , RANCHO SANTA FE, Calif., Dec. 1 /...resveratrol, the ingredient in grapes acclaimed fo...is about to hit the marketplace. ,, (Photo: ht... ) ,, (Logo: http://www.newscom.com/cgi-bin/p...WINETIME(TM) Bar, developed by ResVez, Inc. of Ran...
(Date:12/1/2009)..., , SAN DIEGO, Dec. 1 /PRNewswire-Firs...d supplier of Farming, Nursery and Wellness produc...g agreement with Southern California Micro-Lending...). ,, Yan Skwara, CEO of US Farms, Inc. stated...artnership with Angels in Action utilizing our Alo...
(Date:12/1/2009)..., , BRUSSELS, December 1 /PRNewswire/...rts Agree That Adapting Food,Production and Modes ...s , Prof. John Beddington, Chief Scientif... agricultural policy must be founded on science an...entific advisor with the,responsibility to look at...
(Date:12/1/2009)...Some become so worried about what might happen tha... , TUESDAY, Dec. 1 (HealthDay News) -- Fe...to depression, a new study suggests. , "Anxiety...y author Andres Viana, a graduate student in psych...e with anxiety sensitivity are afraid of their anx...
Breaking Medicine News(10 mins):Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Fear of Anxiety May Lead to Depression 2
Other TagsBioCoatIKAIKAOther Tagsambitious 2stressed 2deadliest 2